シスプラチン不適応または適応の局所進行性扁平上皮頭頸部癌患者における、ニボルマブ単剤療法またはニボルマブ＋シスプラチン併用療法と放射線療法の併用

基本情報

NCT ID

NCT03349710

ステータス

完了

試験のフェーズ

第3相

試験タイプ

介入

目標被験者数

74

治験依頼者名

Bristol-Myers Squibb

概要

This study has two, independent, cohorts, both in locally advanced squamous cell head and neck cancer. The purpose of the first cohort is to determine whether nivolumab in combination with radiotherapy is more effective than cetuximab in combination with radiotherapy, in subjects who are ineligible for cisplatin. The purpose of the second cohort is to determine whether nivolumab, cisplatin, and radiotherapy is more effective than cisplatin and radiotherapy in subjects who are eligible to receive cisplatin

対象疾患

介入

依頼者（Sponsor）